Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
about
Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedemaHuman Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency.International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
P2860
Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Nanofiltered C1 esterase inhib ...... gioedema: an open-label trial.
@en
type
label
Nanofiltered C1 esterase inhib ...... gioedema: an open-label trial.
@en
prefLabel
Nanofiltered C1 esterase inhib ...... gioedema: an open-label trial.
@en
P2093
P1476
Nanofiltered C1 esterase inhib ...... gioedema: an open-label trial.
@en
P2093
David Fitts
David S Hurewitz
Ira Kalfus
Marc A Riedl
Paula J Busse
Robyn Levy
P356
10.1016/J.ANAI.2011.10.017
P577
2011-11-21T00:00:00Z